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RATIONALE: Despite increasing understanding of the prognostic importance of vascular stiffening linked to perivascular fibrosis 
in hypertension, the molecular and cellular regulation of this process is poorly understood.
OBJECTIVES: To study the functional role of microRNA-214 (miR-214) in the induction of perivascular fibrosis and endothelial 
dysfunction driving vascular stiffening.
METHODS AND RESULTS: Out of 381 miRs screened in the perivascular tissues in response to Ang II (angiotensin II)-mediated 
hypertension, miR-214 showed the highest induction (8-fold, P=0.0001). MiR-214 induction was pronounced in perivascular 
and circulating T cells, but not in perivascular adipose tissue adipocytes. Global deletion of miR-214−/− prevented Ang 
II-induced periaortic fibrosis, Col1a1, Col3a1, Col5a1, and Tgfb1 expression, hydroxyproline accumulation, and vascular 
stiffening, without difference in blood pressure. Mechanistic studies revealed that miR-214−/− mice were protected against 
endothelial dysfunction, oxidative stress, and increased Nox2, all of which were induced by Ang II in WT mice. Ang II-
induced recruitment of T cells into perivascular adipose tissue was abolished in miR-214−/− mice. Adoptive transfer of miR-
214−/− T cells into RAG1−/− mice resulted in reduced perivascular fibrosis compared with the effect of WT T cells. Ang II 
induced hypertension caused significant change in the expression of 1380 T cell genes in WT, but only 51 in miR-214−/−. 
T cell activation, proliferation and chemotaxis pathways were differentially affected. MiR-214−/− prevented Ang II-induction 
of profibrotic T cell cytokines (IL-17, TNF-α, IL-9, and IFN-γ) and chemokine receptors (CCR1, CCR2, CCR4, CCR5, 
CCR6, and CXCR3). This manifested in reduced in vitro and in vivo T cell chemotaxis resulting in attenuation of profibrotic 
perivascular inflammation. Translationally, we show that miR-214 is increased in plasma of patients with hypertension and is 
directly correlated to pulse wave velocity as a measure of vascular stiffness.
CONCLUSIONS: T-cell–derived miR-214 controls pathological perivascular fibrosis in hypertension mediated by T cell recruitment 
and local profibrotic cytokine release.
VISUAL OVERVIEW: An online visual overview is available for this article.
Key Words: blood pressure ◼ collagen ◼ fibrosis ◼ hypertension ◼ inflammation
Hypertension continues to be the number one cause of death and disability worldwide.1 While blood pressure reduction improves disease outcomes, cardiovascular risk remains highly elevated indicating that underlying pathological processes are essential in mediating adverse clinical outcomes. Accelerated 
Editorial, see p 1004 | Meet the First Author, see p 944
D
ow
nloaded from
 http://ahajournals.org by on April 21, 2020
ORIGINAL RESEARCH
Nosalski et al T-Cell miRNA-214 Mediates Perivascular Fibrosis
Circulation Research. 2020;126:988–1003. DOI: 10.1161/CIRCRESAHA.119.315428 April 10, 2020  989
vascular aging a hallmark of hypertension underlies all 
of the target organ consequences of the disease.2 It 
encompasses a number of pathophysiologic processes 
including increased vascular oxidative stress, increased 
perivascular inflammation, endothelial dysfunction, all 
leading collectively to augmentation of vascular stiffen-
ing mediated primarily by perivascular fibrosis.3–6 Vascu-
lar stiffening, measured by pulse wave velocity (PWV) is 
uniformly accepted as an important predictor of cardio-
vascular morbidity and mortality.1,7 Therefore, understand-
ing the molecular mechanisms of vascular stiffening is 
essential for development of novel therapies which can to 
reduce cardiovascular risk in hypertension. Inflammation 
has been one of the important common denominators of 
cardiovascular risk8 and arterial stiffness9 and immune 
cell infiltration is pivotal for perivascular fibrosis.6,10–12
While the opposing effects of miR-214 have been 
recently defined in cardiac13,14 and renal15,16 fibrosis, the 
expression and function of miR-214 in vascular fibrosis and 
stiffening remains unknown. Perivascular fibrosis is largely 
dependent on perivascular inflammation.6 Notably, miR-
214 is expressed by immune cells and affects their func-
tions as indicated by studies of tumor immunity17 including 
possible regulation of profibrotic cytokines, such as TGF-
β (transforming growth factor-β) or IL (interleukin)-17.18 
This is important as IL-17-mediated vascular stiffening can 
occur through increasing the deposition of collagen.10
We sought to examine mechanisms responsible for 
aortic stiffening in hypertension focusing on the role of 
microRNAs (miRs) in the regulation of vascular fibrosis. 
Recent studies have shown that perivascular inflammation 
Nonstandard Abbreviations and Acronyms
Ang II angiotensin II
CCL5 C-C motif chemokine ligand 5
eNOS endothelial nitric oxide synthase
IFN-γ interferon-γ
IL interleukin
miR microRNA
PVAT perivascular adipose tissue
PWV pulse wave velocity
TGF-β transforming growth factor β
TNF-α tumor necrosis factor-α
Novelty and Significance
What Is Known?
• Hypertensive vascular stiffening, characterized by peri-
vascular fibrosis, is a determinant of accelerated vas-
cular aging and predictor of cardiovascular morbidity 
and mortality.
• Perivascular fibrosis is mediated by immune cell infil-
tration and linked to Th17 lymphocytes.
• MiR-214 is important in regulating cardiac and renal 
fibrosis and is expressed by immune cells.
What New Information Does This Article  
Contribute?
• MiR-214 is increased in perivascular adipose tissue in 
hypertension, and this increase is observed primarily in 
T cells infiltrating the vessel.
• MiR-214 expression in T cells enables their activation 
and recruitment into perivascular fat in hypertension. 
MiR-214 also regulates T cell profibrotic properties in 
response to prohypertensive stimuli.
• T cell miR-214 is required for perivascular fibrosis, vas-
cular stiffening, and endothelial dysfunction in Ang II 
hypertension.
• Plasma miR-214 is increased in patients with hyper-
tension and directly correlates to pulse wave velocity 
and endothelial function.
Hypertension is associated with vascular stiffening, 
measured by pulse wave velocity, which is a predic-
tor of cardiovascular morbidity and mortality. As 
perivascular inflammation and perivascular fibrosis are 
hallmarks of hypertensive vasculopathy, we aimed to 
identify molecular microRNA regulators of these pro-
cesses. Out of 381 miRs screened in the perivascular 
tissues in response to Ang II (angiotensin II)-mediated 
hypertension, miR-214 showed the highest induc-
tion, localizing primarily to perivascular adipose tissue. 
MiR-214−/− mice were protected from Ang II-induced 
periaortic fibrosis, induction of collagens and vascular 
stiffening independently of blood pressure responses. 
Using a model of adoptive transfer of T cells into 
RAG1−/− mice, we have shown a key role of T-cell–
derived miR-214 in this process. Looking at T cells by 
RNASeq, we observed that Ang II-induced hyperten-
sion caused a significant change in the expression of 
1380 T cell genes in wild-type mice, but only 51 in 
miR-214−/−. T cell activation, proliferation, and chemo-
taxis pathways were differentially affected. This mani-
fested in reduced in vitro and in vivo T cell chemotaxis 
resulting in attenuation of profibrotic perivascular 
inflammation. Finally, we show that plasma miR-214 
is increased in patients with hypertension and is cor-
related to pulse wave velocity (vascular stiffness) and 
flow-mediated dilatation (endothelial dysfunction). We 
propose that miR-214 regulates vascular function and 
may be an important biomarker and possibly future 
therapeutic target in perivascular fibrosis.
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regulates vascular dysfunction and remodeling in hyper-
tension.10,19 Here, we have identified that miR-214 is 
increased in perivascular adipose tissue (PVAT) in hyper-
tension, and that this increase is observed primarily in T 
cells infiltrating the vessel. MiR-214 expression in T cells 
enables their activation and recruitment into perivascu-
lar fat in the context of hypertension. It also regulates 
T cell profibrotic properties in response to prohyperten-
sive stimuli. Translational relevance of these findings 
has been confirmed by the fact that plasma miR-214 is 
increased in hypertension and is directly correlated to 
PWV and endothelial function.
METHODS
The data that support the findings of this study are available from 
the first and corresponding authors upon reasonable request.
The hypertension and perivascular inflammation studies 
have been conducted as described previously.19,20 Hypertension 
was induced in 12-week-old male mice by infusion of Ang II 
(angiotensin II; 490 ng/kg per day) for 14 days via osmotic 
minipumps (Model 2002, Alzet Corporation). Male mice were 
used as this is best validated model for hypertension, particu-
larly in the context of T cell immune responses. C57BL/6 and 
Rag1−/− (B6.129S7-Rag1tm1Mom/J) were obtained from 
Jackson Laboratories. The miR-214−/− mice were kindly gifted 
by Dr Eric Olson previously described which for adoptive transfer 
experiments were backcrossed 7× to C57BL/6 N background. 
All animal experiments were performed in accordance with the 
United Kingdom Animals Scientific Procedures Act 1986 and 
ARRIVE (Animal Research: Reporting of In Vivo Experiments) 
Guidelines and approved by the Home Office (No. 7009021) 
and ethics committee of Jagiellonian University (157/2016). 
All experiments conform the guidelines from Directive 
2010/63/EU of the European Parliament on the protection 
of animals used for scientific purposes. Randomization and 
allocation concealment were performed. Kolmogorov-Smirnov 
test, Shapiro-Wilk, q-q-plots, and histograms were used to test 
normality of data distribution before parametric or nonparamet-
ric tests were applied. Correlation between cells was assessed 
by Spearman rank correlation analysis. Statistical analysis was 
performed using t-test (2-group studies), 1- or 2-way ANOVA 
(>2-group studies) with a Tukey multiple comparison test, 
Kruskal-Wallis test, or Mann-Whitney U test. Data are reported 
as the mean±SEM. P values <0.05 were considered signifi-
cant. Reported P values include multiple comparison correction 
(Bonferroni or FDR). Number of samples is given in individual 
Figure legends and represent biological replicates (mice used 
for experiments). Data based on tail cuff experiments indicate 
that to detect SBP change from 123 to 143 mm Hg, 8 mice/
group are needed to detect significant (P<0.05) difference at 
a power of 80%. Differential gene expression analysis from the 
RNA-Seq experiment was performed using DESeq2 package 
in R (ver. 3.5.1). Raw gene counts of the RNA-Seq analysis 
are available as supplemental material. RNA-Seq datasets are 
deposited in the Gene Expression Omnibus (GEO)-accession 
number GSE143809 database.
Translational study was performed on 51 hypertensive and 
49 normotensive subjects (Clinical Characteristics—Online 
Table I) and included analysis of miR-214 in plasma, PWV, and 
flow-mediated dilatation studies as described previuosly.19,21 
Study was performed according to the Declaration of Helsinki 
and was approved by the Ethics Committee of Jagiellonian 
University. All participants gave written informed consent.
Analysis in patient populations were performed in Statistica 
13 TIBCO using t test for independent samples. Correlation 
between PWV and plasma miR-214 was assessed by 
Spearman rank correlation test and then by multiple regression 
correcting for SBP and age..
A detailed Materials and Methods section is provided in the 
Data Supplement.
RESULTS
miR-214 Is Increased in the Vasculature in Ang 
II-Induced Hypertension
To identify miR potentially important in the regula-
tion of perivascular inflammation and dysfunction in 
hypertension, we performed a TaqMan array analysis in 
perivascular tissue of sham- and Ang II-infused mice. 
Principal component analysis comprising miR tran-
scripts detected a notable separation of sample sets 
(Figure 1A, top). Of 381 assayed miR, 134 showed 
expression below 35th Ct value. Twenty eight showed 
differential expression (Figure 1A and 1B). Fifteen 
were significantly upregulated and 13 were down-
regulated (Figure 1B). MiR-214 was the only over-
expressed miR significantly altered after Bonferroni 
correction showing an 8-fold increase (Figure 1A and 
1B), which was not observed in other members of miR-
199/214 cluster (Figure 1C, top). Similar, although 
less pronounced an increase was observed in the pri-
miR-214 transcript (Figure 1C, bottom). In situ hybrid-
ization (Figure 1D) and RT-PCR (Figure 1E) was used 
to visualize and quantify the induction of miR-214 in 
different areas of the vessel. MiR-214 was increased 
nearly 8-fold in PVAT and only 2-fold in other vessel 
layers. Surprisingly, no increase was observed in pri-
mary adipocytes isolated from PVAT of Ang II-treated 
versus sham mice (Online Figure I). Subsequent inter-
rogation of the effects of Ang II on miR-214 expres-
sion in kidneys, peripheral blood mononuclear cells, 
spleen, and lymph nodes demonstrated its pronounced 
increase in the spleen and peripheral blood mononu-
clear cells (Figure 1E).
To investigate if the miR-214 increase in the PVAT was 
evoked by the direct actions of Ang II or indirectly by blood 
pressure elevation we used the model of pretreatment of 
mice with oral hydralazine (Hyd) and hydrochlorothiazide 
(HCT),11 which reduced blood pressure in spite of Ang II 
infusion from 165±5 mm Hg (placebo; Ang II) to 133±6 
mm Hg (Hyd/HCT; Ang II; Online Figure II). The increase 
in PVAT miR-214 (Figure 1F, left) and pri-miR-214 (Figure 
1F, right) was abolished in Hyd/HCT mice in spite of Ang 
II infusion.
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Figure 1. MiR-214 is increased in the vasculature and immune cells in Ang II (angiotensin II)-induced hypertension.
A, Principal component analysis of miRs in perivascular adipose tissue (PVAT; top) and volcano plot (bottom) in sham and Ang II-treated 
mice. B, Heatmap presenting z-scores calculated from individual miR −ΔCt values of all miRs significantly altered (t-test FDR adj P<0.05; 
n=5–6). C, Levels of miR-214/199 cluster (top) and pri-miR-214 (bottom) in PVAT (n=4–9). D, In situ hybridization of miR-214 in the 
vascular wall. Scale bar=300 and 150 μm. E, Levels of miR-214 in isolated PVAT, vessel wall layers (n=3 replicates of 3 pulled mice—9 mice/
group), kidney, and selected immune organs (n=3–6). F, Levels of miR-214 and pri-miR-214 in PVAT of mice treated with placebo (PBO) or 
hydralazine/hydrocholrothiazide (Hyd/HCT; n=6/group). Data presented as mean±SEM; t-test with FDR correction (C, P values adjusted for 4 
comparisons; miR clusters; E, P values adjusted for 8 comparisons; various organs) or by 2-way ANOVA (for miR-214 level; PAngII×Drug=3.7×10−6, 
PAngII=4.3×10−7, PDrug=1.4×10−5; for pri-miR-214 level; PAngII×Drug=0.018, PAngII=1.2×10−3, PDrug=0.12) with Tukey multiple comparisons test (F; P 
values adjusted for 6 comparisons).
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miR-214−/− Protects From Hypertension-
Induced Vascular Stiffness and Perivascular 
Fibrosis
To understand the functional role of miR-214 in hyper-
tension, we used miR-214−/− mice in which we investi-
gated development of hypertension, as well as vascular 
dysfunction and remodeling. In vivo, miR-214−/− mice 
did not show altered blood pressures either at base-
line or throughout 14-day Ang II infusion evaluated by 
both tail cuff (Figure 2A) and telemetry (Figure 2B). 
Importantly, in spite of that, we observed a significant 
reduction in periaortic collagen accumulation/fibrosis 
in miR-214−/− mice using Picrosirius red and Mas-
son’s trichrome staining (Figure 2C and 2D). In wild-
type mice, aortic Col1a1, Col3a1, and Col5a1 were all 
significantly induced by Ang II, but this increase was 
abolished in miR-214−/− mice (Figure 2E). Further-
more, hydroxyproline accumulation was observed in the 
aortas of Ang II infused WT but not miR-214−/− mice 
(Figure 2F).
Functional consequences of perivascular fibrosis 
were studied using assessment of vascular stiffness. 
MiR-214−/− mice were protected from the develop-
ment of hypertensive vascular stiffening in pressure 
myography in mouse aortas including adventitial layer 
(Figure 3A). Nanoindentation studies utilizing atomic 
force microscopy also showed an increase of Young’s 
modulus of the aortic wall in wild-type mice with Ang 
II infusion, while this increase was abolished in miR-
214−/− mice (Figure 3B).
miR-214 Is Associated With Vascular Stiffness 
in Human Hypertension
To assess translational relevance of these observations 
to human hypertension, we investigated plasma miR-
214 levels in patients with and without hypertension 
(for detailed clinical characteristics, please see Online 
Table I), and in relation to PWV, as a measure of vascu-
lar stiffness.7 MiR-214 levels were higher in patients 
with hypertension (Figure 3C). Notably, there was a 
significant correlation between plasma miR-214 levels 
and PWV (Figure 3D). This relationship remained sig-
nificant in multiple regression analysis after correcting 
for blood pressure and age (miR-214/PWV: β*=0.212; 
P=0.02). No significant relationship between miR-214 
and age was identified by multiple regression.
miR-214 Modulates Vascular TGF-β in Ang II 
Hypertension
To further understand the role of miR-214 in the regu-
lation of perivascular fibrosis, we studied the expres-
sion of Tgfb1 (TGF-β) and fibronectin (FN1). While both 
TGF-β and FN1 were induced in Ang II infused WT mice, 
only TGF-β mRNA and protein induction were abolished 
in the aorta of miR-214−/− mice (Figure 3E and 3F), 
indicating indirect regulation of TGF-β by miR-214.
miR-214 Regulates Vascular Dysfunction and 
Perivascular Inflammation in Hypertension 
Independently of Blood Pressure
A strong link between miR-214 and vascular phenotype 
was further supported by correlations of plasma miR-214 
with NO-dependent endothelial vascular function, mea-
sured by flow-mediated dilatation, but not with the endo-
thelium-independent responses to nitroglycerine (NMD; 
Figure 4A). These observations in humans were corrobo-
rated in miR-214−/− mice, which were protected from the 
development of endothelial dysfunction, demonstrating 
preserved NO-mediated vasodilatation, in spite of Ang 
II-induced hypertension (Figure 4B). No differences in 
nonendothelium-dependent vasorelaxations to sodium 
nitroprusside were observed (Figure 4B). As eNOS 
(endothelial nitric oxide synthase) is a predicted miR-214 
target, changes of eNOS expression could explain altera-
tions of endothelial function. However, in aortas of Ang II-
treated mice, we did not observe changes in total eNOS 
protein, compared with miR-214−/− mice (Figure 4C). 
As oxidative stress is known to mediate both endothe-
lial dysfunction and vascular stiffness in hypertension, 
we next investigated vascular superoxide production 
and Nox2 and Nox4 nicotinamide adenine dinucleotide 
phosphate oxidases. MiR-214−/− mice showed reduced 
induction of vascular oxidative stress upon Ang II infu-
sion, as measured by superoxide production (Figure 4D) 
and Nox2 nicotinamide adenine dinucleotide phosphate 
oxidase mRNA and protein level (Figure 4E and 4F). 
These changes in vascular function and oxidative stress 
were accompanied by reduced perivascular recruitment 
of total leukocytes (Figure 5A) and CD3+ T cells (Fig-
ure 5B) in miR-214−/− hypertensive animals in compari-
son to hypertensive WT mice. Additionally, Ang II infusion 
significantly elevated the total number of macrophages 
and dendritic cells (CD11c+CD11b−) only in WT ani-
mals, but not in miR-214−/− mice (Figure 5C). No signifi-
cant changes were observed with respect to B cells or 
NK cells (Figure 5C).
miR-214 Induction in the T Cells Is Essential for 
Perivascular Fibrosis
To further understand the mechanisms of the effects of 
miR-214 on vascular inflammation in hypertension, we 
next focused on the effects of hypertension on immune 
cell miR-214. In leukocytes isolated from both periph-
eral blood mononuclear cells and PVAT, we observed 
miR-214 induction only within CD3+ cells (T cells), and 
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Figure 2. Pivotal role of miR-214 in the regulation of perivascular fibrosis in Ang II (angiotensin II)-dependent hypertension.
A, Tail-cuff BP in sham and Ang II infused miR-214−/− and WT littermates (n=9/group). B, Systolic BP measured by telemetry at baseline and 
during Ang II infusion (average, left; example readings, right; n=5). C, Perivascular collagen accumulation in picrosirius red (top) and Masson 
trichrome (bottom) staining (representative of n=9; scale bar=300 μm). D, Quantitative analysis of perivascular collagen deposition in Masson 
trichrome (n=9/group). E, Collagen 1, 3, and 5 mRNA in miR-214−/− and WT littermates infused with buffer or Ang II (n=11/group). F, Aortic 
collagen quantification by hydroxyproline assay (n=7 in Sham and n=9 in Ang II). Data presented as mean±SEM; repeated measures 2-way 
ANOVA (A and B), Kruskal-Wallis test with FDR correction (D and F; P values adjusted for 6 comparisons) or 2-way ANOVA with Tukey test (E; P 
values adjusted for 6 comparisons). Overall P values for repeated measures 2-way ANOVA; A (PTime=0.0051, PGroup=1.8×10−8, PTime×Group=0.1378); 
B (PGroup=0.06, PTime=2.6×10−7, PGroup×Time=0.83); for 2-way ANOVA; E, for Col1a1 (PAngII×Genotype=0.003, PAngII=1.3×10−5, PGenotype=0.0035), Col3a1 
(PAngII×Genotype=0.037, PAngII=0.0034, PGenotype=0.033) Col5a1 (PAngII×Genotype=0.028, PAngII=0.0053, PGenotype=0.042), for Kruskal-Wallis; D (P=0.0003) 
and F (P=0.0006).
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Figure 3. Role of miR-214 in the regulation of vascular stiffening in mouse and human hypertension.
A, Thoracic aorta stiffness studied by pressure myography (n=5–8). B, Elastic modulus of adventitial stiffness measured by atomic force 
microscopy (right) with representative force-indentation curves (left; n=5–6/group). C, Circulating miR-214 serum levels in normotensive (Ctr, 
n=49) and patients with hypertension (HTN, n=51). D, Correlation between plasma miR-214 levels and pulse wave velocity (PWV) in humans with 
and without hypertension (n=100). E, TGF-β (transforming growth factor β) and fibronectin mRNA expression in control and hypertensive miR-
214−/− and WT mice (n=4–9/group). F, Protein level of TGF-β and fibronectin in aortas studied by WB (n=5–9). Data presented as mean±SEM 
repeated measures 2-way ANOVA with Bonferroni correction (A), Kruskal-Wallis test with FDR correction (B; P-adjusted for 6 comparisons) or 
2-way ANOVA with Tukey test (E and F; P values adjusted for 6 comparisons) or t-test (C). Spearman rank test was used to assess correlations 
(D). Overall P values for 2-way ANOVA; A (PAngII=1.8×10−5, PGenotype=0.042), PAngII×Genotype=0.097), E for Tgfb1 (PAngII×Genotype=0.0059, PAngII=0.0031, 
PGenotype=0.225), FN1 (PAngII=1.2×10−5, PGenotype=0.266, PAngII×Genotype=0.218); F for TGF-β (PAngII×Genotype=0.0034, PAngII=5.1×10−7, PGenotype=0.0087), 
for FN1 (PAngII=0.0015, PGenotype=0.243, PAngII×Genotype=0.589) and Kruskal Wallis B (P=0.0368).
D
ow
nloaded from
 http://ahajournals.org by on April 21, 2020
ORIGINAL RESEARCH
Nosalski et al T-Cell miRNA-214 Mediates Perivascular Fibrosis
Circulation Research. 2020;126:988–1003. DOI: 10.1161/CIRCRESAHA.119.315428 April 10, 2020  995
Figure 4. Essential role of miR-214 in endothelial dysfunction and vascular oxidative stress in hypertension.
A, Relationship between plasma miR-214 levels and endothelial function (flow mediated dilatation [FMD]) or nonendothelium-dependent 
relaxations to nitroglycerin (NMD) in humans (n=100). B, Isometric tension studies of endothelium dependent (acetylcholine; ACh) and 
independent (sodium nitroprusside [SNP]) vasorelaxations (n=5–7/group) using wire myography in sham buffer and Ang II (angiotensin II) 
infused WT and miR-214−/− mice. C, eNOS (endothelial nitric oxide synthase) protein level in mouse aortas (Western blotting; n=9–12/group). 
D, Aortic superoxide production measured by lucigenin (5 μM) enhanced chemiluminescence (n=7–9/group). E, Aortic Nox2 and Nox4 mRNA 
expression (n=5/group) and (F) protein levels in aortas of sham and Ang II infused miR-214−/− and WT mice (n=9–12/group). Data presented 
as mean±SEM and analyzed by Spearman rank correlation test (A), repeated measures 2-way ANOVA with Bonferroni correction (B) or 2-way 
ANOVA with Tukey post hoc test (C–F; P values adjusted for 6 comparisons). Overall P values for repeated measures 2-way ANOVA; B for 
Ach (PResponse=0.0009, PGroup=0.044, PResponse×Group=0.016) and SNP (PResponse=04.1×10−7, PGroup=0.049, PResponse×Group=0.217). Two-way ANOVA; 
C (PAngII=0.949, PGenotype=0.862, PAngII×Genotype=0.235); D (PAngII×Genotype=0.061, PAngII=0.0042, PGenotype=0.051); E for Nox2 (PAngII×Genotype=0.0062, 
PAngII=0.193, PGenotype=0.203) and Nox4 (PAngII×Genotype=0.331, PAngII=0.002, PGenotype=0.005); F for Nox2 (PAngII=0.0096, PGenotype=0.683, 
PAngII×Genotype=0.116) and Nox4 (PAngII=0.0093, PGenotype=0.924, PAngII×Genotype=0.109).
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Figure 5. Crucial role of miR-214 in regulation of perivascular inflammation in hypertension.
A, Total number of leukocytes and T cells (B) with representative density plots (n=6–9/group). C, Number of perivascular macrophages 
(F4/80+), dendritic cells (CD11c+), B cells (B220+), and NK cells (NK1.1+) per mg of tissue, studied by flow cytometry (n=5–7/group). Data 
presented on volcano plots depicting median (__) and quartiles (….). D, miR-214 induction in T cells (CD3+) and remaining leukocytes (CD3−) in 
Ang II hypertension measured in cells from peripheral blood (left, PBMC n=5–6/group) and from perivascular adipose tissue (PVAT; right, n=3/
group of 3 pulled mice). E, MiR-214 level in PVAT of WT and RAG1−/− animals (n=5–7/group). F, miR-214 in quiescent (direct lysis; control 
mAb) and anti-CD3 mAb activated T cells (n=3–4/group). Data presented as mean±SEM and analyzed by Kruskal-Wallis test (A–C), 2-way 
ANOVA with Tukey post hoc test (D; P values adjusted for 6 comparisons), t-test (E), and by Kruskal-Wallis test with FDR (F; P values adjusted 
for 3 comparisons). Overall P values for Kruskal-Wallis; A (P=0.017), B (P=0.011), C (P=0.06), D (P=0.05), and F (0.0001); 2-way ANOVA; D 
for PBMC (PCD3×AngII=0.0006, PAngII=0.0026, PCD3=0.0006) and PVAT (PAngII=0.024, PCD3=0.115, PCD3×AngII=0.115).
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not in CD3 negative cells (Figure 5D). Furthermore, miR-
214 did not increase in PVAT of RAG-1−/− mice, lack-
ing mature T cells, despite Ang II infusion (Figure 5E). 
This further supports the hypothesis that infiltrating T 
cells are an essential source of the increase of miR-214 
observed in PVAT.
In keeping with the role of blood pressure elevation in 
miR-214 induction, miR-214 was not induced in T cells 
isolated from mice subjected to blood pressure-lowering 
with hydralazine and hydrochlorothiazide (Online Figure 
III). Moreover, we found that 24-hour stimulation of T 
cells using anti-CD3 antibodies elevated miR-214 levels 
in vitro (Figure 5F). In contrast, stimulation of mouse pri-
mary fibroblasts and of primary vascular smooth muscle 
cells, endothelial cells, or THP-1 monocytes in culture 
using Ang II or cytokine combinations did not signifi-
cantly alter miR-214 expression level (Online Figure IV).
To understand the functional role of T cell miR-214 in 
hypertensive vascular remodeling, we performed adop-
tive transfer of either wild type or miR-214−/− T cells to 
RAG1−/− mice and studied perivascular fibrosis and col-
lagen accumulation. We confirmed earlier findings of Wu 
et al11 that RAG1−/− mice are protected from develop-
ment of perivascular fibrosis and it is rescued by adop-
tive transfer of wild type T cells (Figure 6A and 6B). This 
effect was observed only when wild type, but not when 
miR-214−/− T cells were transferred (Figure 6A and 6B), 
while level of hypertension was similar irrespective of T 
cell miR-214 status. This was accompanied by reduced 
aortic collagen expression in RAG1−/− transferred with 
miR-214−/− T cell when compared with WT T cells (Fig-
ure 6C). Similar levels of peripherally reconstituted circu-
lating T cells were found in RAG1−/− mice upon adoptive 
transfer of WT and miR-214−/− cells (Figure 6D). At the 
same time, we found more than a 5-fold reduction of cd3 
mRNA in the PVAT after transfer of miR-214−/− T cells in 
comparison to WT T cell transfer (Figure 6E).
miR-214 and Mineralocorticoid Signaling
As mineralocorticoid signaling is important in modulation of 
both fibrosis and T cell function in hypertension,22 we have 
investigated potential changes of mineralocorticoid signal-
ing in T cells in miR-214−/− mice. Plasma aldosterone lev-
els were unaltered in miR-214−/− mice (Online Figure VA). 
Furthermore, upon Ang II infusion, there were no changes 
in either mineralocorticoid (MR) or glucocorticoid receptor 
(GR) mRNA or protein level in T cells (Online Figure VB 
and VC). We also analyzed the effects of aldosterone on 
anti-CD3 dependent T cell fibrosis-related cytokine mRNA 
in vitro in WT and miR-214−/− T cells. Aldosterone induced 
only TGF-β mRNA in WT T cells, while other studied 
cytokines were not significantly induced. This induction 
was not observed in miR-214−/− mice (Online Figure 
VD). These studies show that MR signaling is unlikely to a 
play critical role in the effects of miR-214 on perivascular 
fibrosis.
Transcriptional Profiling Reveals Crucial Role of 
miR-214 in Hypertensive T Cell Activation
To understand how miR-214 in the T cell could modulate 
the profibrotic T cell phenotype in hypertension, we per-
formed RNASeq analysis of isolated splenic T cells from 
sham and Ang II infused WT and miR-214−/− mice. This 
analysis has shown that in vivo Ang II infusion induced at 
least a 2-fold change in 1380 genes in WT T cells, while 
miR-214−/− T cells remained greatly unresponsive with 
only 51 genes altered (Figure 7A). Relevant gene sets 
significantly affected by Ang II hypertension in WT T cells 
included cytokine metabolic processes, leukocyte migra-
tion, leukocyte cell-cell adhesion, and the regulation of T 
cell activation. None of these were changed in miR-214−/− 
(Figure 7B). Only 19 of these genes overlapped between 
WT and miR-214−/− further emphasizing the extent of 
the reprogramming of hypertensive T cells by miR-214. 
This is also exemplified by diversity of genes which are 
significantly induced in WT but not in miR-214−/− T cells 
(Figure 7C; analysis using interaction term with FDR cor-
rection). Conversely, a large number of the top 50 genes 
significantly repressed in WT T cells, but not in miR-214−/− 
T cells were the predicted targets for this miR (Figure 7D), 
further supporting a pleiotropic role of miR-214 in tran-
scriptional reprograming of T cells by Ang II.
miR-214 Regulates T Cell Activation and 
Chemotaxis in Hypertension
Following the analysis of our RNASeq data, we next 
studied mRNA and protein levels of key proinflammatory 
and profibrotic cytokines upon Ang II-induced hyperten-
sion. mRNA expression was studied in activated T cells 
isolated from spleens of sham and Ang-II infused WT 
or miR-214−/− mice. As expected, Ang II hypertension 
caused increased induction of Il17a, Tgfb1 Tnfa, Il9, 
Ccl5, and Ifng in the WT T cells. MiR-214−/− mice were 
protected from this induction (Figure 8A). The effects 
of miR-214 on the induction of T cell protein levels of 
IL-17, TNF-α (tumor necrosis factor-α), Il-9, and IFN-
γ (interferon-γ) in vivo were confirmed by intracellular 
staining using flow cytometry (Figure 8B).
Chemokine-dependent perivascular recruitment of 
T cells is essential for vascular dysfunction19 and aortic 
stiffening.11 To further investigate this phenomenon, we 
studied expression of relevant chemokine receptors in 
normotensive and hypertensive WT and miR-214−/− mice. 
We observed induction of CCR1, CCR2, CCR4, CCR5, 
and CCR6 as well as CXCR3 on the surface of T cells in 
Ang II hypertension (Figure 8C). These increases were not 
observed in miR-214−/− mice (Figure 7C), suggesting that 
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reduced chemotaxis of these cells can explain decreased 
T cell recruitment in miR-214−/− mice. Therefore, we next 
investigated the role of miR-214 in the regulation of T cell 
chemotaxis in vitro using the Boyden chamber and in vivo 
air-pouch experiments (Figure 8D and 8E). Peripheral 
blood T cells from the miR-214−/− mice infused with Ang 
II exhibited reduced chemotaxis towards key chemokines 
involved in hypertension—CCL5 (C-C motif chemokine 
Figure 6. T cell miR-214 mediates perivascular fibrosis and profibrotic T cell accumulation in PVAT (perivascular adipose tissue) 
in Ang II (angiotensin II)- induced hypertension.
A, Vascular collagen accumulation in response to Ang II-hypertension assessed using picrosirius red (left) and Massons trichrome (right; scale 
bar=300 μm, representative of n=4–5/group) with quantification of adventitial collagen (B) in RAG1−/− mice and upon adoptive transfer of WT 
and miR-214−/− T cells (n=4–5/group). C, Ang II-dependent induction of Col 1, 3, and 5 mRNA in aortas of RAG1−/− transferred with WT or 
miR-214−/− T cells (n=4–5). D, Levels of circulating T cells in RAG1−/− mice and upon adoptive transfer of WT or miR-214−/− T cells (left) with 
representative dot plots (right; n=4–5/group). E, CD3 mRNA in PVAT of RAG1−/− mice and upon adoptive transfer of WT or miR-214−/− T cells 
(n=4–5/group). Data presented as mean±SEM and analyzed by 1-way ANOVA with Tukey post hoc t test (B, D, E; P values adjusted for 6 
comparisons), t-test with FDR (C; P values adjusted for 3 comparisons). Overall P values for 1-way ANOVA; B (P=6.3×10−5), D (P=1.5×10−8), 
and E (P=7.8×10−6).
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Figure 7. Essential role of miR-214 in T cell responses in Ang II (angiotensin II)-induced hypertension.
A, Genes with absolute log2FC>1, significantly (FDR adj P<0.05 calculated using Wald test in DESeq2) changed in T cells following 2-week 
AngII infusion in vivo in WT (left) and mir214−/− (right) mice (n=3). Venn diagram indicates total numbers of genes changed in each strain of mice 
in response to Ang II. B, Top 30 pathways significantly upregulated in WT T cells following 2-weeks AngII infusion in vivo in WT mice. C, Top 50 
genes (based on interaction term estimate) preferentially induced by Ang II infusion in WT when compared with mir214−/− mice (FDR adj Pinteraction 
<0.05 for all presented). D, Top 50 genes preferentially repressed by AngII infusion in WT as compared with miR-214−/− mice. Predicted targets 
of miR-214 for miRWalk (# red) and TargetScan 7.1 (# green). Data on heat maps are presented as z-scores of log transformed, normalized 
gene read counts (Log NRC) calculated with DESeq2.
D
ow
nloaded from
 http://ahajournals.org by on April 21, 2020
OR
IG
IN
AL
 R
ES
EA
RC
H
Nosalski et al T-Cell miRNA-214 Mediates Perivascular Fibrosis
1000  April 10, 2020 Circulation Research. 2020;126:988–1003. DOI: 10.1161/CIRCRESAHA.119.315428
Figure 8. MiR-214 modulates T cell proinflammatory cytokine production, chemokine receptors expression and T cells 
migration in Ang II (angiotensin II)-induced hypertension.
A, Heatmap of selected profibrotic cytokine mRNA in T cells upon Ang II-induced hypertension in WT (left) and miR-214−/− (right) mice. Gene 
expression was studied upon ex vivo activation by anti-CD3 and anti-CD28 for 24 h (n=3–4/group) and presented as fold change, relative 
to average of sham. B, Cytokine production by T cells in sham buffer and Ang II infused WT and miR-214−/− mice (n=4–6/group) upon 6-h 
stimulation with PMA studied by flow cytometry. C, T cell chemokine surface receptors in sham and (Continued )
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ligand 5) and CXCL10 when compared with WT mice 
(Figure 8D). This observation was confirmed using an in 
vivo chemotaxis model, in which T cell recruitment into 
the air-pouch wall was inhibited by miR-214−/− in Ang II-
hypertensive mice (Figure 8E).
DISCUSSION
We have identified the role of miR-214 in mediating 
perivascular fibrosis in hypertension. We link these 
pathophysiological effects of elevated miR-214 to the T 
cell compartment that infiltrates the PVAT and induces 
the fibrotic response. MiR-214 affects global change of 
transcriptomic profile in T cells in hypertension, enabling 
their activation and recruitment into perivascular fat. 
It also regulates the development of T cell profibrotic 
properties in hypertension. These mechanistic studies 
in mice led us to show in humans that plasma miR-214 
is increased in hypertension and is significantly associ-
ated with PWV and endothelial dysfunction in hyperten-
sive subjects. Hence, miR-214 is a new target linking 
the T-cell inflammatory cascade to vascular complica-
tions of hypertension.
While our study is the first to link miR-214 to vascu-
lar dysfunction and perivascular fibrosis, earlier studies 
have shown that miR-214 regulates cardiac and renal 
fibrosis in the conditions of organ-selective stress. MiR-
214 repression is protective in the setting of unilateral 
ureteral obstruction-induced renal fibrosis and damage, 
but at the same time miR-214 loss exacerbates cardiac 
fibrosis evoked by ischemia-reperfusion injury.13 Those 
studies indeed highlight the organ-specific context in 
which miRNAs can drive opposing responses, presum-
ably due to the different cell types, in which the miRNA is 
expressed in and the cell-specific transcriptome induced 
in response to different pathogenic stimuli.
We report that miR-214−/− mice are protected from 
the development of endothelial dysfunction, a hallmark 
of hypertension,23 despite the similar blood pressure 
response to Ang II. While this might be regulated by the 
role of miR-214 in the endothelium itself, we have pre-
viously shown that T cell infiltration into the vessel wall 
induces endothelial dysfunction mainly through IFN-γ-
dependent mechanisms.19 In line with these observations, 
miR-214−/− prevented T cell activation and IFN-γ release.
The mechanisms through which T cells and their 
cytokines such as IL-17, IFN-γ, TNF-α, and TGF-β can 
affect perivascular fibrosis have been previously dem-
onstrated.24–28 In our model, TGF-β seems to be the 
most evident regulator of fibrosis in aortas from Ang 
II hypertensive mice. Its induction is alleviated in miR-
214−/− mice, even though TGF-β is not a direct target of 
miR-214. This effect may however be explained by the 
fact that TGF-β expression in fibroblasts may be induced 
by T-cell–derived cytokines, such as IFN-γ, TNF-α, or 
IL-17.24
Induction of miR-214 in PVAT and T cells is depen-
dent on blood pressure increases, rather than by direct 
actions of Ang II. This is in line with earlier observations 
that T cell activation and vascular recruitment depend 
on pressure increase and are in part dependent on 
mechanical stretch,11 which involves and affects anti-
gen presenting cell activation.29 Taking into account 
that miR-214 increases in T cells upon activation and 
perivascular T cell infiltration increases 3- to 4-fold in 
hypertension, T cell infiltration into PVAT may provide the 
most compelling mechanism of miR-214 increase in this 
compartment in Ang II-induced hypertension. Moreover, 
miR-214 seems to regulate T cell activation character-
ized by profibrotic effector cytokine production and che-
mokine receptor expression. The mechanisms of this are 
complex and not fully understood. RNASeq analysis of 
isolated T cells showed that Ang II causes profound tran-
scriptional changes, which are lost in miR-214−/− T cells. 
It is difficult to molecularly dissect a single repressor of T 
cell activation and migration that could be responsible for 
the effects of miR-214. RNASeq suggested that miR-
214 in the T cells has a broad pleotropic effect, leading 
to global change in T cell activation in hypertension. The 
combined effect of these alterations is likely responsible 
for the beneficial phenotypic changes in hypertension. 
Further studies are needed to fully understand all the 
pathways central to these effects orchestrating vascu-
lar inflammation and stiffness and to develop possible 
selective therapeutic targeting approaches.
While our study shows the role of miR-214 in T cell 
activation and cytokine production in hypertension for 
the first time, one should be cautious in attempts to 
apply these findings to other inflammatory conditions. 
For example, miR-214 decreases in relapsing phase of 
Figure 8 Continued. Ang II-infused WT and miR-214−/− mice studied by flow cytometry with representative histograms (n=4–6/group). D, In 
vitro chemotaxis of T cells obtained from hypertensive animals toward CXCL10 and CCL5 in Boyden chambers (n=6/group) with representative 
dot plots reflecting control and chemokine induced migration. E, Air pouch model of T cell chemotaxis (top) showing T cell recruitment toward 
membranes surrounding air-pouch filled with carrageenan and recombinant proteins (CXCL10 and CCL5) in hypertensive WT and miR-214−/− 
mice with representative density plots (n=3–4/group). Data presented as mean±SEM and analyzed by t-test with FDR (All genes show FDR 
adj P<0.05 in WT but not in miR-214−/−), Mann-Whitney U test (D) or t-test (E). Two-way ANOVA with Tukey (B and C; P values adjusted for 6 
comparisons). Overall P values for 2-way ANOVA; B for IFN (PAngII×Genotype=0.0073, PAngII=0.0068, PGenotype=0.0988), TNF (PAngII×Genotype=0.0475, 
PAngII=0.0001, PGenotype=0.0042), IL17a (PAngII=0.0007, PGenotype=0.1316, PAngII×Genotype=0.0814) and IL9 (PAngII=0.0045, PGenotype=0.0245, 
PAngII×Genotype=0.0994); C for CCR1 (PAngII×Genotype=0.0413, PAngII=0.0198, PGenotype=0.2508), CCR2 (PAngII×Genotype=0.0467, PAngII=0.0452, 
PGenotype=0.1193), CCR4 (PAngII×Genotype=0.0081, PAngII=0.0022, PGenotype=0.0013), CCR5 (PAngII× Genotype=0.0142, PAngII=0.0047, PGenotype=0.0186), 
CCR6 (PAngII×Genotype=0.0445, PAngII=0.0066, PGenotype=0.0596), CXCR3 (PAngII=0.0167, PGenotype=0.0771, PAngII×Genotype=0.163).
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multiple sclerosis, which is accompanied by increased 
Th17 cells.18
Interestingly, we observe that the induction of major 
hypertensive cytokines is inhibited in T cells from Ang 
II-infused miR-214−/− mice, but no effects on blood 
pressure responses was seen in this model. This is sur-
prising but may reflect a complex role of cytokines at 
different stages of hypertension, as well as a possible 
differential role of vascular and renal inflammation at 
different stages of hypertension. In fact, our blood pres-
sure data are in contrast to very recent suggestions 
that intrarenal application of antagomir targeting miR-
214-3p significantly attenuated salt-induced hyperten-
sion and albuminuria in SS rats. miR-214-3p directly 
targeted eNOS in Dahl salt-sensitive rats.16 However, in 
our model, we did not see decreases in eNOS expres-
sion in the vessels upon Ang II infusion. This discrep-
ancy may be related to different model of hypertension 
used. Congenic Dahl salt-sensitive rat used in that 
study is primarily kidney-dependent,30 which may con-
tribute to observed difference. Interdependence with 
other immune cells involved in hypertension, such as B 
cells,31 macrophages,32 and NK cells33 should be con-
sidered as well. While our studies do not show miR-214 
induction in non-T cell immune cells, their role may be 
upstream from the T cell in immune activation.33
Finally, it is important to note that we reported that 
miR-214 is increased in plasma of patients with hyper-
tension and is linked to PWV as a measure of vascular 
stiffening in humans.34 Thus, miR-214 might serve as 
a valuable biomarker of vascular stiffening. Moreover, 
considering the pivotal role of miR-214 in regulating 
vascular inflammation, endothelial dysfunction, oxida-
tive stress, and perivascular fibrosis, all constituting ele-
ments of accelerated vascular aging, our study indicates 
a possibility of the use of miR-214 as a biomarker of 
accelerated vascular aging and in the future targeting T 
cell miR-214 to target this important process. Our stud-
ies also emphasize the need to identify novel therapies 
inhibiting T cell activation and their recruitment in cardio-
vascular diseases.35,36
In summary, we have identified that miR-214 is an 
essential regulator of T cell dependent mechanisms of 
vascular stiffening, fibrosis, and dysfunction in hyperten-
sion. It may represent a novel biomarker and a possible 
target for modulation of perivascular inflammation.
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